Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers

Hatcher, 2008, Curcumin: from ancient medicine to current clinical trials, Cell Mol Life Sci, 65, 1631, 10.1007/s00018-008-7452-4 Niranjan, 2013, Biochemical composition of Curcuma longa L. accessions, Anal Lett, 46, 1069, 10.1080/00032719.2012.751541 Henrotin, 2013, Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management, Springerplus, 2, 56, 10.1186/2193-1801-2-56 Sandur, 2007, Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism, Carcinogenesis, 28, 1765, 10.1093/carcin/bgm123 Yun, 2011, Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin, J Nutr Biochem, 22, 450, 10.1016/j.jnutbio.2010.03.014 Senft, 2010, The nontoxic natural compound curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas, BMC Cancer, 10, 491, 10.1186/1471-2407-10-491 Cekmen, 2009, Curcumin prevents oxidative renal damage induced by acetaminophen in rats, Food Chem Toxicol, 47, 1480, 10.1016/j.fct.2009.03.034 Cemil, 2010, Curcumin improves early functional results after experimental spinal cord injury, Acta Neurochir (Wien), 152, 1583, 10.1007/s00701-010-0702-x Naik, 2004, Protection of liver cells from ethanol cytotoxicity by curcumin in liver slice culture in vitro, J Ethnopharmacol, 95, 31, 10.1016/j.jep.2004.06.032 Jantan, 2012, Effects of diarylpentanoid analogues of curcumin on chemiluminescence and chemotactic activities of phagocytes, J Pharm Pharmacol, 64, 404, 10.1111/j.2042-7158.2011.01423.x Uddin, 2005, Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma, Oncogene, 24, 7022, 10.1038/sj.onc.1208864 Fadus, 2017, Curcumin: an age-old anti-inflammatory and anti-neoplastic agent, J Tradit Complement Med, 7, 339, 10.1016/j.jtcme.2016.08.002 Sharma, 2007, Pharmacokinetics and pharmacodynamics of curcumin, Adv Exp Med Biol, 595, 453, 10.1007/978-0-387-46401-5_20 Gupta, 2010, Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals, Cancer Metastasis Rev, 29, 405, 10.1007/s10555-010-9235-2 Gupta, 2013, Therapeutic roles of curcumin: lessons learned from clinical trials, AAPS J, 15, 195, 10.1208/s12248-012-9432-8 Kelloff, 1996, Strategy and planning for chemopreventive drug development: clinical development plans II, J Cell Biochem Suppl, 26, 54, 10.1002/jcb.240630705 Priyadarsini, 2014, The chemistry of curcumin: from extraction to therapeutic agent, Molecules, 19, 20091, 10.3390/molecules191220091 Wang, 1997, Stability of curcumin in buffer solutions and characterization of its degradation products, J Pharm Biomed Anal, 15, 1867, 10.1016/S0731-7085(96)02024-9 Loftsson, 2005, Cyclodextrins in drug delivery, Expert Opin Drug Deliv, 2, 335, 10.1517/17425247.2.1.335 Grynkiewicz, 2012, Curcumin and curcuminoids in quest for medicinal status, Acta Biochim Pol, 59, 201, 10.18388/abp.2012_2139 Jurenka, 2009, Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research, Altern Med Rev, 14, 141 Cuomo, 2011, Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation, J Nat Prod, 74, 664, 10.1021/np1007262 Gota, 2010, Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers, J Agric Food Chem, 58, 2095, 10.1021/jf9024807 Krishnakumar, 2012, An enhanced bioavailable formulation of curcumin using fenugreek-derived soluble dietary fibre, J Funct Food, 4, 348, 10.1016/j.jff.2012.01.004 Madhavi, 2014, Bioavailability of a sustained release formulation of curcumin, Integr Med (Encinitas), 13, 24 Schiborr, 2014, The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes, Mol Nutr Food Res, 58, 516, 10.1002/mnfr.201300724 Jager, 2014, Comparative absorption of curcumin formulations, Nutr J, 13, 11, 10.1186/1475-2891-13-11 Antony, 2008, A pilot cross-over study to evaluate human oral bioavailability of BCM-95CG (Biocurcumax), a novel bioenhanced preparation of curcumin, Indian J Pharm Sci, 70, 445, 10.4103/0250-474X.44591 Shoba, 1998, Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers, Planta Med, 64, 353, 10.1055/s-2006-957450 Purpura, 2018, Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects, Eur J Nutr, 57, 929, 10.1007/s00394-016-1376-9 Sasaki, 2011, Innovative preparation of curcumin for improved oral bioavailability, Biol Pharm Bull, 34, 660, 10.1248/bpb.34.660 Semalty, 2010, Supramolecular phospholipids-polyphenolics interactions: the PHYTOSOME strategy to improve the bioavailability of phytochemicals, Fitoterapia, 81, 306, 10.1016/j.fitote.2009.11.001 Sinha, 2001, Polysaccharides in colon-specific drug delivery, Int J Pharm, 224, 19, 10.1016/S0378-5173(01)00720-7 Rasenack, 2002, Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs, Pharm Res, 19, 1894, 10.1023/A:1021410028371 Bhardwaj, 2002, Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4, J Pharmacol Exp Ther, 302, 645, 10.1124/jpet.102.034728 Carrier, 2007, The utility of cyclodextrins for enhancing oral bioavailability, J Control Release, 123, 78, 10.1016/j.jconrel.2007.07.018 Sibbald, 1998, Understanding controlled trials. Why are randomised controlled trials important?, BMJ, 316, 201, 10.1136/bmj.316.7126.201 Wellek, 2012, On the proper use of the crossover design in clinical trials: part 18 of a series on evaluation of scientific publications, Dtsch Arztebl Int, 109, 276 Mushref, 2013, Effect of high fat-diet and obesity on gastrointestinal motility, Ann Transl Med, 1, 14 Vareed, 2008, Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects, Cancer Epidemiol Biomarkers Prev, 17, 1411, 10.1158/1055-9965.EPI-07-2693 Kadi, 2009, Biological fluids: glucuronides from LC/MS, Encycl Chromatogr, 203 Xia, 2009, Rapid Commun Mass Spectrom, 23, 2125, 10.1002/rcm.4121 Jamwal, 2017, Ultra-high performance liquid chromatography tandem mass-spectrometry for simple and simultaneous quantification of cannabinoids, J Chromatogr B Analyt Technol Biomed Life Sci, 1048, 10, 10.1016/j.jchromb.2017.02.007 Tan, 2013, Use of internal standards in LC–MS bioanalysis, 217